Encontrados 3 documentos, a visualizar página 1 de 1

Ordenado por Data

Natural polymorphisms of HIV type 2 pol sequences from drug-naive individuals

Parreira, R.; Monteiro, F.; Pádua, E.; Piedade, J.; Venenno, T.; Paixão, M.T.; Esteves, A.

Until today, the susceptibility of human immunodeficiency virus type 2 (HIV-2) to protease and nucleosidic reverse-transcriptase inhibitors (PI and NRTI, respectively) has not been clearly documented. In this report we studied HIV-2 proviral sequences (n = 30) from drug-naive patients. Our results revealed that several amino acid positions in the protease and reverse transcriptase coding sequence harbored resid...


Human Immunodeficiency Virus type 1 seroincidence estimate among a group of dru...

Fernandes, S Bio; Centro de Virologia, Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisboa.; Martins, H Cortes; Trigo, H; Leitão, E; Coutinho, R

Estimating Human Immunodeficiency Virus type 1 (HIV-1) infection remains one of the great challenges of the epidemiologic surveillance of HIV-1 epidemics. WHO has recently approved a laboratory based strategy that enables the identification of recent infections.To identify the number of recent (incident) infections and estimate the seroincidence of HIV-1, using for the first time in Portugal, a new methodology ...

Data: 2005   |   Origem: Acta Médica Portuguesa

Natural variation of the nef gene in human immunodeficiency virus type 2 infect...

Pádua, E.; Jenkins, A.; Brown, S.; Bootman, J.; Paixão, M.T.; Almond, N.; Berry, N.

Human immunodeficiency virus type 2 (HIV-2) infections cause severe immunodeficiency in humans, although HIV-2 is associated frequently with reduced virulence and pathogenicity compared to HIV-1. Genetic determinants that play a role in HIV pathogenesis are relatively poorly understood but nef has been implicated in inducing a more pathogenic phenotype in vivo. However, relatively little is known about the role...


3 Resultados

Texto Pesquisado

Refinar resultados

Autor











Data




Tipo de Documento


Recurso



Assunto













    Financiadores do RCAAP

Fundação para a Ciência e a Tecnologia Universidade do Minho   Governo Português Ministério da Educação e Ciência Programa Operacional da Sociedade do Conhecimento União Europeia